Eolas Medical raises almost £9m to scale knowledge platform

Digital health firm Eolas Medical has raised $12 million (£8.9m) to scale its knowledge platform for clinical decision-making.

The Series A funding, led by Acton Capital, will drive the firm’s growth in the UK and Ireland, as well as support international expansion of its point-of-care knowledge tools.

Eolas’ ​​web and mobile apps aim to replace intranets and fragmented document stores with a single source of truth, giving clinicians access to approved local guidance, policies and medicines information.

​​​Declan Kelly, founder and chief executive of Eolas Medical, said: “Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it.

“This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely – particularly in the winter.

“As AI develops, the next phase is about making that access even more usable, so staff can ask a question and get a clear, evidence-backed answer straight away, in plain language.

“We’re delighted that our investor partners recognise the importance of our bespoke AI knowledge tool, so we can build on what’s already working across the NHS and support organisations as pressure builds on services and care continues to move beyond traditional hospital settings.”

The Eolas platform includes a new AI-powered search which allows staff to ask questions and receive results sourced from their organisation’s internal resources, speeding up decisions without compromising governance or clinical oversight.

Elisha Zafar, specialist infection pharmacist at King’s College Hospital NHS Foundation Trust, which uses the platform, said: “Working in infection at King’s means dealing with everything from the most routine to the most complex cases, across a hugely diverse patient population.

“We’re juggling massive workloads all the time, so being able to get to the right information quickly makes a real difference to how we work.

“The search function is the biggest benefit. You type in a few letters, and it searches across all the guidelines using the keywords we’ve built in. It’s really easy to find what you need.

​​“​At the moment, we’re using it for all our infection guidelines. The trust has seen how well it’s worked for us, so now we’re embedding more guidelines and phasing out the old King’s guideline system.

“As most other trusts host their guidelines on Eolas, this allows us to see how practice is approached across different organisations, particularly in specialist centres or those with a similar patient cohort to our own.”

Eolas is embedded in more than 400 UK clinical sites and used by 85% of NHS acute trusts.

Fritz Oidtmann, managing partner at Acton Capital, said: “Our conversations with clinicians showed remarkable enthusiasm for Eolas.

“Clinicians love the product. The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical.”